Stock comparison
Amicus Therapeutics
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
FOLD
Amicus Therapeutics
Market cap
$4.55B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | FOLD | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 42D | 69B | MTD |
| Benjamin Graham | 66D | 65B | FOLD |
| Philip Fisher | 52C | 63C | MTD |
| Peter Lynch | 54C | 66B | MTD |
| Joel Greenblatt | 69C | 68B | FOLD |
| Charlie Munger | 41D | 74B | MTD |
| Terry Smith | 37D | 70B | MTD |
Side-by-side metrics
| Metric | FOLD | MTD |
|---|---|---|
| Market cap | $4.55B | $22.29B |
| P/E (TTM) | - | 25.3x |
| EV/EBIT | 139.7x | 21.6x |
| ROIC (TTM) | -6.46% | 36.09% |
| Gross margin | 87.91% | 57.79% |
| Net margin | -4.27% | 21.4% |
| Revenue CAGR 5y | 20.03% | 2.01% |
| EPS CAGR 5y | - | 6.12% |
| Debt / Equity | 1.8x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
FOLD leads on
- P/E (TTM)-vs 25.3x+115%
- Revenue CAGR 5y20.03%vs 2.01%+90%
- Gross margin87.91%vs 57.79%+34%
MTD leads on
- Net margin21.4%vs -4.27%+120%
- ROIC (TTM)36.09%vs -6.46%+106%
- Debt / Equity-vs 1.8x+103%
- EV/EBIT21.6xvs 139.7x+85%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.